Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 326 of 326 entries
Sorted by: Best Match Show Resources per page
Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis.

Human pathology

Fitzpatrick MB, Hammer PM, Yang EJ, Howitt BE.
PMID: 34856302
Hum Pathol. 2021 Nov 29;120:18-25. doi: 10.1016/j.humpath.2021.11.009. Epub 2021 Nov 29.

Intravenous leiomyomatosis (IVL) is a quasi-malignant smooth muscle tumor involving lymphatic and venous spaces of the myometrium. Rare cases of IVL with admixed endometrial glands and stroma have been described, termed intravascular adenomyomatosis. We report four additional cases of...

Cite
Fitzpatrick MB, Hammer PM, Yang EJ, et al. Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis. Hum Pathol. 2021;120:18-25doi: 10.1016/j.humpath.2021.11.009.
Fitzpatrick, M. B., Hammer, P. M., Yang, E. J., & Howitt, B. E. (2021). Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis. Human pathology, 12018-25. https://doi.org/10.1016/j.humpath.2021.11.009
Fitzpatrick, Megan B, et al. "Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis." Human pathology vol. 120 (2021): 18-25. doi: https://doi.org/10.1016/j.humpath.2021.11.009
Fitzpatrick MB, Hammer PM, Yang EJ, Howitt BE. Intravascular adenomyomatosis: a morphologic variant of intravenous leiomyomatosis associated with endometriosis and potential for misdiagnosis. Hum Pathol. 2021 Nov 29;120:18-25. doi: 10.1016/j.humpath.2021.11.009. Epub 2021 Nov 29. PMID: 34856302.
Copy Download .nbib Format: NLM
Coagulation profile of human COVID-19 convalescent plasma.

Scientific reports

Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW.
PMID: 35022488
Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1.

Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study was to evaluate the...

Cite
Klompas AM, van Helmond N, Juskewitch JE, et al. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022;12(1):637doi: 10.1038/s41598-021-04670-1.
Klompas, A. M., van Helmond, N., Juskewitch, J. E., Pruthi, R. K., Sexton, M. A., Soto, J. C. D., Klassen, S. A., Senese, K. A., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Hammel, S. A., Joyner, M. J., & Senefeld, J. W. (2022). Coagulation profile of human COVID-19 convalescent plasma. Scientific reports, 12(1), 637. https://doi.org/10.1038/s41598-021-04670-1
Klompas, Allan M, et al. "Coagulation profile of human COVID-19 convalescent plasma." Scientific reports vol. 12,1 (2022): 637. doi: https://doi.org/10.1038/s41598-021-04670-1
Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1. PMID: 35022488; PMCID: PMC8755772.
Copy Download .nbib Format: NLM
Showing 325 to 326 of 326 entries